Drawing for LAIGO BIO

USPTO serial 79353322

LAIGO BIO

Reviewed by CopyMark Law Group

Reg. 7220678Status 700Registered
Filing date
Status date
Registration date
Nov 21, 2023
Examiner
CARROLL, DORITT
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LAIGO BIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth A. Cominolli

Elizabeth A. Cominolli Markert & Cominolli PLLC75 S. Clinton Ave., Suite 510Rochester, NY 14604UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, medicinal preparations for the treatment of cancer, inflammation, neurodegeneration and immune disorders; pharmaceutical preparations for the treatment and the prevention of diseases and disorders, namely, anti-cancer, anti-inflammation, anti-neurodegeneration and immunological preparations; colostral antibodies for medical purposesACTIVE—
042Scientific research; development of pharmaceutical preparations and medicines; medical and pharmacological research services; research, testing and inspection of pharmaceuticals; medical and pharmacological research and development services in the field of antibodies; creation and maintenance of websites for others in the field of medical research and pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 26, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 26, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 21, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 21, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 21, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 4, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 16, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 16, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 16, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 28, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 27, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 27, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 2, 2023RFNTREFUSAL PROCESSED BY IB—
Apr 8, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 8, 2023RFRRREFUSAL PROCESSED BY MPU—
Feb 19, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 18, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2023DOCKASSIGNED TO EXAMINER—
Oct 25, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 21, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 20, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance